[go: up one dir, main page]

DE69116321D1 - Immunostimulierendes Mittel das Interleukin-2 und 5'-Deoxy-5-fluorouridin enthält - Google Patents

Immunostimulierendes Mittel das Interleukin-2 und 5'-Deoxy-5-fluorouridin enthält

Info

Publication number
DE69116321D1
DE69116321D1 DE69116321T DE69116321T DE69116321D1 DE 69116321 D1 DE69116321 D1 DE 69116321D1 DE 69116321 T DE69116321 T DE 69116321T DE 69116321 T DE69116321 T DE 69116321T DE 69116321 D1 DE69116321 D1 DE 69116321D1
Authority
DE
Germany
Prior art keywords
fluorouridine
deoxy
agent containing
containing interleukin
immunostimulating agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69116321T
Other languages
English (en)
Other versions
DE69116321T2 (de
Inventor
Koichiro Ootsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DE69116321D1 publication Critical patent/DE69116321D1/de
Application granted granted Critical
Publication of DE69116321T2 publication Critical patent/DE69116321T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55533—IL-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69116321T 1990-11-29 1991-11-28 Immunostimulierendes Mittel das Interleukin-2 und 5'-Deoxy-5-fluorouridin enthält Expired - Fee Related DE69116321T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32547590 1990-11-29

Publications (2)

Publication Number Publication Date
DE69116321D1 true DE69116321D1 (de) 1996-02-22
DE69116321T2 DE69116321T2 (de) 1996-05-23

Family

ID=18177298

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69116321T Expired - Fee Related DE69116321T2 (de) 1990-11-29 1991-11-28 Immunostimulierendes Mittel das Interleukin-2 und 5'-Deoxy-5-fluorouridin enthält

Country Status (5)

Country Link
US (1) US5250296A (de)
EP (1) EP0488718B1 (de)
AT (1) ATE132756T1 (de)
CA (1) CA2056555A1 (de)
DE (1) DE69116321T2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
US5641665A (en) * 1994-11-28 1997-06-24 Vical Incorporated Plasmids suitable for IL-2 expression
EP0806956B1 (de) 1995-02-01 2002-08-28 RESprotect GmbH Verwendung von 5' substituierten nukleosiden zur hemmung von resistenzbildung bei der zytostatikabehandlung
WO2000050021A2 (en) * 1999-02-26 2000-08-31 Napro Biotherapeutics, Inc. Treatment regimen for prostate cancer, initiated after androgen ablative therapy has started
JP4638098B2 (ja) * 1999-06-14 2011-02-23 キャンサー・リサーチ・テクノロジー・リミテッド 癌治療
JP2004505047A (ja) 2000-07-28 2004-02-19 キャンサー・リサーチ・テクノロジー・リミテッド 複合治療による癌治療
WO2002015934A1 (fr) * 2000-08-25 2002-02-28 Takeda Chemical Industries, Ltd. Agents prophylactiques et remedes contre des maladies du systeme nerveux central
DE10108851A1 (de) * 2001-02-23 2002-09-12 Resprotect Gmbh Verwendung von 5'-substituierten Nukleosiden und/oder deren Prodrugs zur resistenzfreien Therapie von Infektionskrankheiten
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
MA40094B1 (fr) * 2014-08-06 2022-05-31 Univ Miami Protéines de fusion de l'interleukine-2/récepteur alpha de l'interleukine-2 et procédés d'utilisation
CA3094112A1 (en) 2018-03-28 2019-10-03 Bristol-Myers Squibb Company Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56126088A (en) * 1980-03-06 1981-10-02 Kawasaki Steel Corp Production of clad steel
JPH0751511B2 (ja) * 1982-03-15 1995-06-05 味の素株式会社 インターロイキン２を含有してなる癌治療剤
DE3377363D1 (en) * 1982-03-31 1988-08-18 Ajinomoto Kk Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
JPS60115528A (ja) * 1983-11-28 1985-06-22 Takeda Chem Ind Ltd ヒトインタ―ロイキン―２蛋白質を含有する抗腫瘍用または免疫機能低下疾患治療用組成物
DE3572982D1 (en) * 1984-03-06 1989-10-19 Takeda Chemical Industries Ltd Chemically modified lymphokine and production thereof
IL76360A0 (en) * 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins
DK585886A (da) * 1985-12-24 1987-06-25 Takeda Chemical Industries Ltd Immunstimulerende middel og anvendelse deraf

Also Published As

Publication number Publication date
CA2056555A1 (en) 1992-05-30
ATE132756T1 (de) 1996-01-15
EP0488718A3 (en) 1993-03-17
US5250296A (en) 1993-10-05
EP0488718A2 (de) 1992-06-03
EP0488718B1 (de) 1996-01-10
DE69116321T2 (de) 1996-05-23

Similar Documents

Publication Publication Date Title
CY1646A (en) Use of n-(4-phenoxy-2,6-diisopropylphenyl)-n'-tert.butylthiourea in the control of white flies
NO905125D0 (no) Administrerings-innretning.
FR2669092B1 (fr) Mecanisme d'entrainement alternatif et scie sauteuse le comportant.
NO891213L (no) Fleksible laminater.
DE68909693D1 (de) Angetriebenes Atemgerät.
NO902188L (no) Kateter med tilbakestroemnings-innsnevring.
DE58904591D1 (de) Schiebetuervorrichtung.
FI890689L (fi) 3-alkenyl-1-azabicyklo-/3.2.0/ -hept-2-en-2-karboxylsyrafoereningar.
DE69021383D1 (de) Medizinisches beatmungsgerät.
DE68907682D1 (de) Luefter mit verstellbaren stufen.
ATA19888A (de) Schienen-zieh- bzw. -verschiebe-vorrichtung
FI890611L (fi) 3'-deamino-4'-deoxi-4'-amino -antracykliner.
DE68909080D1 (de) Linearmotor und diesen Linearmotor benutzende Linearantriebsvorrichtung.
DE69116321D1 (de) Immunostimulierendes Mittel das Interleukin-2 und 5'-Deoxy-5-fluorouridin enthält
KR900700567A (ko) 2,3-디플루오로비페닐
DE69112988D1 (de) Befestigungsvorrichtung im Raum.
GB8918604D0 (en) Driving device for pumps or the like
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
NO892523D0 (no) Skinnebane for pendeldrift og med usymmetrisk plassert moetestrekning, og fremgangsmaate for aa oeke banens kollisjonssikre minsteavstand.
EP0401262A4 (en) 24r-scymnol, and preparation and use thereof
NO901956L (no) Fleksibel multiplekser.
FI893366L (fi) 4-piperidylmetyl-2,3-dihydro-1h -isoindol- och 2,3,4,5-tetrahydro-1h-bensasepinderivat, deras framstaellning och terapeutiska anvaendning.
IT8920483A0 (it) 10 norantracicline.
KR900000020U (ko) 콤바인 2번구 환원장치
DK396089A (da) 6-aroyl-substituerede 3,4-dihydro-2h-benzopyraner samt fremstilling og anvendelse deraf

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee